Testing effectiveness (Phase 2)Study completedNCT00005795What this trial is testingArsenic Trioxide in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Northwestern University 11
Early research (Phase 1)Study completedNCT00003395What this trial is testingArsenic Trioxide in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00899795What this trial is testingEvaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy VolunteersWho this might be right forLeukemiaMyelodysplastic Syndromes OHSU Knight Cancer Institute 35
Testing effectiveness (Phase 2)Study completedNCT00070135What this trial is testingFludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete RemissionWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Alliance for Clinical Trials in Oncology 121
Testing effectiveness (Phase 2)Study completedNCT03749460What this trial is testingNivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland CancersWho this might be right forMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the LungSalivary Gland Carcinoma+4 more University of Washington 20
Testing effectiveness (Phase 2)WithdrawnNCT00081055What this trial is testingOTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Mesoblast International Sàrl
Testing effectiveness (Phase 2)Study completedNCT01812252What this trial is testingChemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell TransplantWho this might be right forChronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+1 more Fred Hutchinson Cancer Center 50
Not applicableStudy completedNCT00608855What this trial is testingPercutaneous Cryoablation in Treating Patients With Painful Bone MetastasesWho this might be right forMetastatic CancerPainUnspecified Adult Solid Tumor, Protocol Specific Mayo Clinic 60
Testing effectiveness (Phase 2)Ended earlyNCT00052598What this trial is testingTherapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more Fred Hutchinson Cancer Center 7
Early research (Phase 1)Ended earlyNCT01260714What this trial is testingAzacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00049504What this trial is testingHaploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)Study completedNCT00002798What this trial is testingCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeWho this might be right forChildhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Monoblastic Leukemia (M5a)+13 more National Cancer Institute (NCI) 880
Large-scale testing (Phase 3)Study completedNCT02364557What this trial is testingTesting Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves SurvivalWho this might be right forAnatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Bone+6 more NRG Oncology 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT03643133What this trial is testingMifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma PatientsWho this might be right forOsteosarcoma UNICANCER 60
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Large-scale testing (Phase 3)UnknownNCT04550949What this trial is testingTo Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid TumorsWho this might be right forBone Metastases Qilu Pharmaceutical Co., Ltd. 700
Testing effectiveness (Phase 2)Study completedNCT00068276What this trial is testingCholecalciferol in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Wake Forest University Health Sciences
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06987058What this trial is testingRVU120 Rollover StudyWho this might be right forAdvanced Solid TumorsAcute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome Ryvu Therapeutics SA 14